|
Volumn 10, Issue 8, 2007, Pages 513-516
|
American Society of Clinical Oncology - 43rd annual meeting. Research into therapeutics: Part 1
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AB 1010;
AMG 655;
ANTINEOPLASTIC AGENT;
AXITINIB;
BAY 734506;
CYCLIN DEPENDENT KINASE 2 INHIBITOR;
DOXORUBICIN;
DTS 201;
E 7974;
GENMAB;
HISTONE DEACETYLASE INHIBITOR;
JNJ 16241199;
LIVER ENZYME;
MASITINIB;
MONOCLONAL ANTIBODY;
MOTESANIB DIPHOSPHATE;
PAZOPANIB;
PD 332991;
PF 562271;
PHOSPHOTRANSFERASE INHIBITOR;
R 1507;
R 306465;
ROMIDEPSIN;
TAXANE DERIVATIVE;
TPI 287;
UNCLASSIFIED DRUG;
VASCULOTROPIN INHIBITOR;
VASCULOTROPIN RECEPTOR 1;
VASCULOTROPIN RECEPTOR 3;
ABDOMINAL PAIN;
ADVANCED CANCER;
ALOPECIA;
ANEMIA;
ANOREXIA;
ANTIANGIOGENIC ACTIVITY;
AREA UNDER THE CURVE;
ASTHENIA;
BONE MARROW SUPPRESSION;
CANCER CHEMOTHERAPY;
CARDIOTOXICITY;
CLINICAL TRIAL;
COLORECTAL CANCER;
CONFERENCE PAPER;
CONSTIPATION;
DIARRHEA;
DRUG CLEARANCE;
DRUG DISTRIBUTION;
DRUG DOSE ESCALATION;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG FEVER;
DRUG HALF LIFE;
DRUG SAFETY;
DRUG TOLERABILITY;
EDEMA;
FATIGUE;
FOOD DRUG INTERACTION;
GASTROINTESTINAL DISEASE;
GASTROINTESTINAL STROMAL TUMOR;
GASTROINTESTINAL SYMPTOM;
HEAD AND NECK CANCER;
HUMAN;
HYPERTENSION;
HYPOMAGNESEMIA;
HYPOTENSION;
HYPOTHYROIDISM;
LEUKOPENIA;
LUNG NON SMALL CELL CANCER;
MUCOSA INFLAMMATION;
MULTIPLE CYCLE TREATMENT;
NAUSEA;
NEUROPATHY;
NEUTROPENIA;
PANCREAS CANCER;
PERIORBITAL EDEMA;
RECOMMENDED DRUG DOSE;
SIDE EFFECT;
SKIN DISEASE;
SKIN MANIFESTATION;
SOLID TUMOR;
STOMATITIS;
THYROID CANCER;
UNSPECIFIED SIDE EFFECT;
VOMITING;
WEAKNESS;
ANTINEOPLASTIC AGENTS;
BIOMEDICAL RESEARCH;
BRIDGED COMPOUNDS;
CLINICAL TRIALS;
DOXORUBICIN;
HUMANS;
MOLECULAR STRUCTURE;
NEOPLASMS;
PRODRUGS;
TAXOIDS;
TREATMENT OUTCOME;
|
EID: 34547524676
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (1)
|
References (0)
|